wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q53103129-4FBC7D9A-889B-4F87-BAC1-A5CB0C42A1F1
Q53103129-4FBC7D9A-889B-4F87-BAC1-A5CB0C42A1F1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53103129-4FBC7D9A-889B-4F87-BAC1-A5CB0C42A1F1
Health policy: Me-too drugs with limited benefits - the tale of regorafenib for HCC.
P2860
Q53103129-4FBC7D9A-889B-4F87-BAC1-A5CB0C42A1F1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53103129-4FBC7D9A-889B-4F87-BAC1-A5CB0C42A1F1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
279bee9ffc8c1f3cc9fb31ae01471f479d09e9ce
P2860
Oral anticancer drugs: how limited dosing options and dose reductions may affect outcomes in comparative trials and efficacy in patients.